(Q48114584)

8 February 2018

title

Effect of a glutamate receptor antagonist (GYKI 52466) on 4-aminopyridine-induced seizure activity developed in rat cortical slices. (English)

1 reference

8 February 2018

1 reference

Dóczi J

1

1 reference

8 February 2018

Banczerowski-Pelyhe I

series ordinal

2

1 reference

8 February 2018

Barna B

series ordinal

3

1 reference

8 February 2018

Világi I

series ordinal

4

1 reference

8 February 2018

publication date

1 August 1999

1 reference

8 February 2018

published in

Brain Research Bulletin

1 reference

8 February 2018

volume

49

1 reference

8 February 2018

issue

6

1 reference

8 February 2018

page(s)

435-440

1 reference

8 February 2018

Laminar analysis of the origin of the various components of evoked potentials in slices of rat sensorimotor cortex.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

GABA-mediated synchronous potentials and seizure generation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Effects of potassium channel blockade on endogenous glutamate release from cerebellar slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Recruitment of inhibition by enhanced activation of synaptic NMDA responses in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Distinct modes of channel gating underlie inactivation of somatic K+ current in rat hippocampal pyramidal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Epileptogenesis in neocortical slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Anticonvulsant action of excitatory amino acid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The role of potassium channels in excitable cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Animal models of the epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Mechanisms of neocortical epileptogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Components of field potentials evoked by white matter stimulation in isolated slices of primary visual cortex: spatial distributions and synaptic order.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Laminar organization of epileptiform discharges in the rat entorhinal cortex in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Potassium channel activators counteract anoxic hyperexcitability but not 4-aminopyridine-induced epileptiform activity in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Extracellular K+ accumulations and synchronous GABA-mediated potentials evoked by 4-aminopyridine in the adult rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Changes in excitatory and inhibitory synaptic potentials leading to epileptogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Mechanism of aminopyridine-induced ictal seizure activity in the cat neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Effect of 4-aminopyridine on transmitter release in synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

N-methylaspartate receptors mediate epileptiform activity evoked in some, but not all, conditions in rat neocortical slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

Effects of NMDA- and AMPA-receptor antagonists on different forms of epileptiform activity in rat temporal cortex slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900079-9

7 January 2021

10.1016/S0361-9230(99)00079-9

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10483921

1 reference

8 February 2018